This program would allow clinical pharmacists throughout North Carolina to assess the prevalence of Peripheral Artery Disease PAD in general population vs diabetes patients. Pharmacists would provide patients with education regarding drug and non-drug therapies as well as referralsfollow-up. PAD screenings would be provided at no cost to general patient populations in the community pharmacy andor health fair settings. Data will be aggregated and submitted for publication.
Kerr Drug Inc.